This paper deals with statistical (non-implicational) semantic maps, built automatically using classical multidimensional scaling from a direct comparison of parallel text data (the Gospel according to Mark) in the domain of motion events (case/adpositions) in 153 languages from all continents in 190 parallel clauses. The practical objective is to present one way (among other possible ways) in which semantic maps can be built easily and fully automatically from large typological datasets (Section 3). Its methodological objective is to demonstrate that semantic maps can be built in various ways and that the sampling of languages and small differences in the method chosen to build a semantic map can have a strong influence on the results (Section 4). This does not mean that semantic space is arbitrary, but rather that it is dynamic (having stretching and shrinking dimensions). The theoretical aim of this paper is to discuss similarity semantics, the implicit theoretical basis behind the semantic map approach, and to show that similarity semantics is not novel, but has a long-standing tradition in philosophy and psychology (Section 2).
Parallel texts are texts in different languages that can be considered translational equivalent. We introduce the notion ‘massively parallel text’ for such texts that have translations into very many languages. In this introduction we discuss some massively parallel texts that might be used for the investigation of linguistic diversity. Further, a short summary of the articles in this issue is provided, finishing with a prospect on where the investigation of parallel texts might lead us.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.